79,10 €
87,89 €
-10% with code: EXTRA
HIV/TB-MR patients on a short course of multidrug-resistant tuberculosis
HIV/TB-MR patients on a short course of multidrug-resistant tuberculosis
79,10
87,89 €
  • We will send in 10–14 business days.
A retrospective descriptive study was conducted in patients with MDR-TB in CAT, Cocody and Treichville Pneumo-Physiology Departments, from November 2013 to December 2015. Sputum from included patients was cultured monthly for 9 months. Out of 132 patients put on a short 9-month regimen, 22 (16.66%) were HIV infected including 6 cases of relapse and 4 lost to follow-up. At the consolidation phase of the short course of MDR-TB, cultures were negative for 14/18 (77.77%) and positive for 4/18 (22.2…
  • SAVE -10% with code: EXTRA

HIV/TB-MR patients on a short course of multidrug-resistant tuberculosis (e-book) (used book) | bookbook.eu

Reviews

Description

A retrospective descriptive study was conducted in patients with MDR-TB in CAT, Cocody and Treichville Pneumo-Physiology Departments, from November 2013 to December 2015. Sputum from included patients was cultured monthly for 9 months. Out of 132 patients put on a short 9-month regimen, 22 (16.66%) were HIV infected including 6 cases of relapse and 4 lost to follow-up. At the consolidation phase of the short course of MDR-TB, cultures were negative for 14/18 (77.77%) and positive for 4/18 (22.22%). The D516V mutation in the rpoB gene was the most frequent among cured patients with 42.85%. One failure was observed in a patient infected with a double mutated strain (L511P, S522T). Among the failures, 2 patients were XDR. The estimated Od ratio according to rpoB gene mutation type and clinical category was 0.81 95% CI [0.13;20.57] and 0.27 95% CI [0.002; 2.82], respectively. The type of rpoB mutation and clinical category did not influence the treatment outcome of HIV/TBMR co-infected patients.

EXTRA 10 % discount with code: EXTRA

79,10
87,89 €
We will send in 10–14 business days.

The promotion ends in 12d.14:50:58

The discount code is valid when purchasing from 10 €. Discounts do not stack.

Log in and for this item
you will receive 0,88 Book Euros!?

A retrospective descriptive study was conducted in patients with MDR-TB in CAT, Cocody and Treichville Pneumo-Physiology Departments, from November 2013 to December 2015. Sputum from included patients was cultured monthly for 9 months. Out of 132 patients put on a short 9-month regimen, 22 (16.66%) were HIV infected including 6 cases of relapse and 4 lost to follow-up. At the consolidation phase of the short course of MDR-TB, cultures were negative for 14/18 (77.77%) and positive for 4/18 (22.22%). The D516V mutation in the rpoB gene was the most frequent among cured patients with 42.85%. One failure was observed in a patient infected with a double mutated strain (L511P, S522T). Among the failures, 2 patients were XDR. The estimated Od ratio according to rpoB gene mutation type and clinical category was 0.81 95% CI [0.13;20.57] and 0.27 95% CI [0.002; 2.82], respectively. The type of rpoB mutation and clinical category did not influence the treatment outcome of HIV/TBMR co-infected patients.

Reviews

  • No reviews
0 customers have rated this item.
5
0%
4
0%
3
0%
2
0%
1
0%
(will not be displayed)